newsfilter
← Latest News
GlobeNewswire·

miRagen Reports Second Quarter 2020 Financial Results and Provides Business Updates

Progress on next generation microRNA-29 mimic for use in pulmonary fibrosis (MRG-229) includes new preclinical data; additional NIH grant funding triggeredExploratory preclinical safety and...